EntreChem is going Back to the Future of Drug Discovery

12/08/2016 - 2 minutes

We leave the Netherlands with a smile after visiting FF Pharma in Utrecht this week. Once again, we depart to another part of Europe and this time we’re heading to the North of Spain. Oviedo, the main capital of the Spanish Asturias region, is our final destination and is also where EntreChem, our Biotech of the Week, is located!


City: Oviedo (Spain)

Founded: 2006

Employees: 12

Financial Data: €6M Total Raised (as 12/2015)

CEO: Francisco Morís


Mission: EntreChem wants to take a step back in drug discovery to explore the possibilities of data-driven science in drug discovery, relying on novel products obtained by metabolic engineering.

While modern drug discovery focuses mainly on finding a molecule to target a certain disease mechanism (such as inhibiting one receptor), earlier drugs were actually discovered by seeing the overall effect in an organism with a certain disease.

EntreChem believes this is a better strategy to tackle complicated disease mechanisms (protein-protein interactions,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT Do you want to remove this advert? Become a member!
ADVERTISEMENT Do you want to remove this advert? Become a member!

Support Us

Become a Member